Hepatitis C Virus (HCV) Infection, the Importance of Genotyping
DOI:
https://doi.org/10.46966/msjar.v6i1.246Keywords:
HCV, Infection, GenotypingAbstract
Hepatitis C virus (HCV) is an enveloped, single stranded positive-sense RNA virus discovered in the late eighties, circulating HCV antibody (anti-HCV) aided in diagnosis and screening of blood products minimizing post blood transfusion spread to a large extent, it is still highly prevalent in underdeveloped areas and it contribute largely to chronic liver diseases and hepatocellular carcinoma, One of the important features of HCV is its prominent genetic variability where new genetic polymorphism are emerging frequently and this has a great impact on treatment deciissions including the emergence of drug resistant strains among difeerent genotypes specially genotype 3, accordingly the Direct-Acting Antivirals (DAAs) including NS3/4A protease inhibitors, NS5A inhibitors and NS5B polymerase inhibitors are used in combination for patients initially treated and for those who have regimen failure. Unfortunately, still the studies of polymorphism and drug susceptibilities in Iraq are scarce and deficient.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Iman Jabbar Kadhim
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
